News Archive
Although there is currently no treatment approved by the Federal Drug Administration (FDA) for acute attacks of hereditary angioedema (HAE) - a genetic disease causing swelling of extremities, face and internal organs that can be life-threatening - hope is on the horizon according to a team of experts presenting the latest research at the Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Dallas.
Although there is general agreement on the optimal calcium intake recommended for reducing postmenopausal bone loss, and it is recognized that vitamin D is important in calcium maintenance, the optimal intake of vitamin D is controversial, according to background information in the article.
It is well-documented that when negotiating winding roads, drivers tend to look at a specific, well-defined point on the lane marking - referred to as the tangent point. New research finds that the further drivers can look ahead, generally in left-hand curves, wide curves and when leaving a curve, the less they have to look at the tangent point.
ARYx Therapeutics, Inc., a biopharmaceutical company, today announced that is has received guidance in writing from the U.S. Food and Drug Administration (FDA) confirming that the existing development pathway remains acceptable to seek regulatory approval of ARYx's novel anticoagulant agent, tecarfarin (ATI-5923).
Potentially lethal heart conditions may become easier to spot and may lead to improvements in prevention and treatment thanks to innovative new software that measures electrical activity in the organ.
› Verified 4 days ago